These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1237182)

  • 21. Cooperativity of warfarin binding with human serum albumin induced by free fatty acid anion.
    Chakrabarti SK
    Biochem Pharmacol; 1978 Mar; 27(5):739-43. PubMed ID: 656112
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of heavy metals on the in vitro interaction between human serum albumin and warfarin.
    Chakrabarti SK
    Biochem Pharmacol; 1978; 27(24):2957-9. PubMed ID: 736986
    [No Abstract]   [Full Text] [Related]  

  • 23. Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids.
    Sellers EM; Koch-Weser J
    Clin Pharmacol Ther; 1970; 11(4):524-9. PubMed ID: 5429179
    [No Abstract]   [Full Text] [Related]  

  • 24. Thermodynamics of fatty acid anion displacement of warfarin and phenylbutazone from human albumin.
    Rippie EG
    Biochem Pharmacol; 1976 May; 25(10):1215-6. PubMed ID: 938544
    [No Abstract]   [Full Text] [Related]  

  • 25. Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs.
    Sellers EM; Koch-Weser J
    Ann N Y Acad Sci; 1971 Jul; 179():213-25. PubMed ID: 5285376
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rodenticidal action of warfarin/4th communication: Binding to serum albumin of mice and rats (author's transl)].
    von Oettingen U; Niedner R; Meyer F
    Arzneimittelforschung; 1975 Nov; 25(11):1705-6. PubMed ID: 1243077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of enflurane, halothane and the halothane metabolite trifluoroacetic acid with the binding of acidic drugs to human serum albumin. An in vitro study.
    Dale O
    Biochem Pharmacol; 1986 Feb; 35(4):557-61. PubMed ID: 3947389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced warfarin binding of albumin variants.
    Wilding G; Blumberg ES; Vesell ES
    Science; 1977 Mar; 195(4282):991-4. PubMed ID: 841323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.
    Sjöholm I; Ekman B; Kober A; Ljungstedt-Påhlman I; Seiving B; Sjödin T
    Mol Pharmacol; 1979 Nov; 16(3):767-77. PubMed ID: 530258
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of competitive displacement agents to resolve albumin binding problems observed during the development of a radioimmunoassay for ICI 215001.
    Ballard P; Malone MD; Law B
    J Pharm Biomed Anal; 1994 Jan; 12(1):47-52. PubMed ID: 7909237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
    Maes V; Engelborghs Y; Hoebeke J; Maras Y; Vercruysse A
    Mol Pharmacol; 1982 Jan; 21(1):100-7. PubMed ID: 7132952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stopped-flow studies on drug-protein binding. 1. Kinetics of warfarin binding to human serum albumin.
    Rietbrock N; Lassmann A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Sep; 313(3):269-74. PubMed ID: 7432558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs.
    Brown KF; Crooks MJ
    Biochem Pharmacol; 1976 May; 25(10):1175-8. PubMed ID: 820348
    [No Abstract]   [Full Text] [Related]  

  • 34. Peculiar chiral discrimination of bovine serum albumin to (+/-)-N-dansyl-norleucine.
    Abe Y; Yasuoka S; Shoji T; Sugata S; Hattori K; Iwata K; Suzuki H
    Anal Sci; 2002 Jul; 18(7):823-5. PubMed ID: 12137381
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-protein binding: recent advances in methodology: spectroscopic techniques.
    Chignell CF
    Ann N Y Acad Sci; 1973 Nov; 226():44-59. PubMed ID: 4129140
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of temperature on binding of warfarin by human serum albumin.
    Oester YT; Keresztes-Nagy S; Mais RF; Becktel J; Zaroslinski JF
    J Pharm Sci; 1976 Nov; 65(11):1673-7. PubMed ID: 994000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of coumarin anticoagulants to human and bovine serum albumin. Circular dichroism studies.
    Brown NA; Müller WE
    Pharmacology; 1978; 17(4):233-8. PubMed ID: 567809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced optical activity following the binding of warfarin, indomethacin, 4-hydroxycoumarin and salicylic acid to human serum albumin.
    Perrin JH; Nelson DA
    Life Sci I; 1972 Mar; 11(6):277-83. PubMed ID: 4653203
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of perfluorochemical emulsion components on human albumin binding of warfarin.
    Parsons DL; Nadkarni SR
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):165-74. PubMed ID: 3675079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural requirements for binding of nonsteroidal anti-inflammatory drugs to human serum albumin.
    Li KL; Thakur AK; Kapoor AL
    J Pharm Sci; 1988 Mar; 77(3):251-4. PubMed ID: 3373430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.